H.C. Wainwright Starts Moleculin Biotech (MBRX) at Buy

June 9, 2025 6:14 AM UTC Send to a Friend
H.C. Wainwright analyst Sara Nik initiates coverage on Moleculin Biotech ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login